<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>GE Healthcare &#8211; 元哲咨询</title>
	<atom:link href="https://www.yuanzhezixun.com/tag/ge-healthcare/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.yuanzhezixun.com</link>
	<description>行业研究专家</description>
	<lastBuildDate>Sun, 29 Jan 2023 03:43:39 +0000</lastBuildDate>
	<language>zh-Hans</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.yuanzhezixun.com/wp-content/uploads/2021/10/cropped-shcrilogo-c-45x45.jpg</url>
	<title>GE Healthcare &#8211; 元哲咨询</title>
	<link>https://www.yuanzhezixun.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2021-2025年中国碘克沙醇市场研究报告</title>
		<link>https://www.yuanzhezixun.com/iodoxanol-market-research-report/</link>
		
		<dc:creator><![CDATA[Timlee]]></dc:creator>
		<pubDate>Tue, 13 Apr 2021 02:31:14 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[GE Healthcare]]></category>
		<category><![CDATA[VISIPAQUE]]></category>
		<category><![CDATA[典淳宁]]></category>
		<category><![CDATA[北陆药业]]></category>
		<category><![CDATA[威视派克]]></category>
		<category><![CDATA[恒瑞医药]]></category>
		<category><![CDATA[扬子江药业]]></category>
		<category><![CDATA[显苏]]></category>
		<category><![CDATA[晴立明]]></category>
		<category><![CDATA[正大天晴]]></category>
		<category><![CDATA[碘克沙醇]]></category>
		<category><![CDATA[碘克沙醇区域分析]]></category>
		<category><![CDATA[碘克沙醇市场]]></category>
		<category><![CDATA[碘克沙醇市场份额]]></category>
		<category><![CDATA[碘克沙醇市场报告]]></category>
		<category><![CDATA[碘克沙醇市场竞争]]></category>
		<category><![CDATA[碘克沙醇市场细分]]></category>
		<category><![CDATA[碘克沙醇市场规模]]></category>
		<category><![CDATA[造影剂]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=23643</guid>

					<description><![CDATA[CRI元哲的调研数据显示碘克沙醇在中国市场2016-2020的销售额呈上升趋势。2020年的年销售额约为14.9亿元，2016-2020的CAGR为27%。。2020年相较于前几年增长速度有所减缓，主要原因是COVID-19疫情的影响使得2020年中国医院手术台数大幅减少。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>全球重症肌无力市场研究报告预测至2023年</title>
		<link>https://www.yuanzhezixun.com/quanqiuzhongzhengjiwulishichangyanjiubaogaoyucezhi2023nian/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Tue, 23 Apr 2019 06:33:55 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Alexion Pharmaceuticals]]></category>
		<category><![CDATA[and Valeant Pharmaceuticals International]]></category>
		<category><![CDATA[Baxter]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[CSL Behring]]></category>
		<category><![CDATA[GE Healthcare]]></category>
		<category><![CDATA[Grifols S.A.]]></category>
		<category><![CDATA[KONINKLIJKE PHILIPS N.V.]]></category>
		<category><![CDATA[Medtronic PLC]]></category>
		<category><![CDATA[Novartis AG.]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Shire]]></category>
		<category><![CDATA[重症肌无力]]></category>
		<category><![CDATA[重症肌无力市场]]></category>
		<category><![CDATA[重症肌无力市场报告]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=19509</guid>

					<description><![CDATA[重症肌无力（MG）是一种免疫系统神经肌肉疾病，其主要作用是减少AChRs在肌肉终板膜上的会聚。北美和拉丁美洲共同致力于全球重症肌无力市场的发展。与此同时，欧洲和亚太地区在价值方面占据第二和第三位。最近重症肌无力的优势已经显着上升，这促使治疗要求急剧增加。预计全球重症肌无力市场在预计期间（2018-2023）的年增长率为9.61％。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>全球精准医药市场（2018-2023）</title>
		<link>https://www.yuanzhezixun.com/quanqiujingzhunyiyaoshichang2018-2023/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Tue, 16 Apr 2019 03:21:53 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Almac Group]]></category>
		<category><![CDATA[GE Healthcare]]></category>
		<category><![CDATA[GlaxoSmithKline (GSK)]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Novartis AG.]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Quest Diagnostics]]></category>
		<category><![CDATA[Randox Laboratories]]></category>
		<category><![CDATA[Teva Pharmaceutical industries]]></category>
		<category><![CDATA[精准医药]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=19051</guid>

					<description><![CDATA[全球精准医药市场受益于生命科学行业的进步。尽管处于初期阶段，但由于有可能治疗和治疗慢性疾病，因此靶向治疗在未来几年中有很大的机会成功取得巨大成功。因此预计2018年至2023年期间市场将以11.60％的复合年增长率（CAGR）扩张，到2023年将产生88.25亿美元的收入。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>全球远程医疗市场（2018-2023）：在2017 &#8211; 2022年期间以14.1％的复合年增长率扩张</title>
		<link>https://www.yuanzhezixun.com/quanqiuyuanchengyiliaoshichang2018-2023/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Tue, 16 Apr 2019 03:09:35 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[Allscripts Healthcare]]></category>
		<category><![CDATA[Cerner]]></category>
		<category><![CDATA[Cisco]]></category>
		<category><![CDATA[GE Healthcare]]></category>
		<category><![CDATA[Honeywell]]></category>
		<category><![CDATA[LifeWatch]]></category>
		<category><![CDATA[McKesson]]></category>
		<category><![CDATA[Medtronic]]></category>
		<category><![CDATA[Philips Healthcare]]></category>
		<category><![CDATA[Siemens Healthineers]]></category>
		<category><![CDATA[移动健康]]></category>
		<category><![CDATA[远程医疗]]></category>
		<category><![CDATA[远程患者监测]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=19043</guid>

					<description><![CDATA[由于专业医疗保健的高成本，远程皮肤病学的应用在应用领域中是最高的。该部分包括皮肤病学并提供先进的成像技术。紧随其后的是远程放射学（25％）和远程心脏病学（24％）。远程心脏病学是由全世界心脏疾病患病率较高以及特定心脏病引起的，如心律失常需要长期持续监测。癌症患者需要定期检查，这对于远离医院的患者可能是不可能的。远程放射学对这些患者来说是一个福音，使他们能够过上健康的生活。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>心脏成像软件市场研究 &#8211; 全球预测至2023年：市场将以8.17％的复合年增长率增长</title>
		<link>https://www.yuanzhezixun.com/xinzangchengxiangruanjianshichangyanjiu-quanqiuyucezhi2023nian/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Wed, 16 Jan 2019 01:57:33 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[计算机/互联网/电商]]></category>
		<category><![CDATA[3mensio Medical Imaging]]></category>
		<category><![CDATA[Agfa Healthcare]]></category>
		<category><![CDATA[Cardiac Imaging Software]]></category>
		<category><![CDATA[CardioComm Solutions Inc.]]></category>
		<category><![CDATA[Circle Cardiovascular Imaging Inc.]]></category>
		<category><![CDATA[Creavo Medical Technologies]]></category>
		<category><![CDATA[eMedica]]></category>
		<category><![CDATA[Fujifilm Holdings Corporation]]></category>
		<category><![CDATA[GE Healthcare]]></category>
		<category><![CDATA[Heart Imaging Technologies]]></category>
		<category><![CDATA[HeartSciences]]></category>
		<category><![CDATA[Integer Holdings Corporation]]></category>
		<category><![CDATA[KONINKLIJKE PHILIPS N.V.]]></category>
		<category><![CDATA[Mckesson Corporation]]></category>
		<category><![CDATA[Medis medical imaging systems]]></category>
		<category><![CDATA[Pie Medical Imaging]]></category>
		<category><![CDATA[Pixmeo SARL]]></category>
		<category><![CDATA[Positron Corporation]]></category>
		<category><![CDATA[Shimadzu Corporation]]></category>
		<category><![CDATA[Siemens Healthineers]]></category>
		<category><![CDATA[TOMTEC IMAGING SYSTEMS GMBH]]></category>
		<category><![CDATA[Toshiba Corporation]]></category>
		<category><![CDATA[心脏成像软件]]></category>
		<category><![CDATA[心脏成像软件市场]]></category>
		<category><![CDATA[心脏成像软件市场主要企业]]></category>
		<category><![CDATA[心脏成像软件市场区域分析]]></category>
		<category><![CDATA[心脏成像软件市场规模]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=17002</guid>

					<description><![CDATA[通过软件捕获的实时图片有助于更好地诊断和治疗疾病，重复发生的可能性较小或没有。预计2017 - 2023年全球心脏成像软件市场将以8.17％的复合年增长率增长。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
		<item>
		<title>全球家庭医疗保健市场研究报告 &#8211; 全球预测截至2023年</title>
		<link>https://www.yuanzhezixun.com/quanqiujiatingyiliaobaojianshichangyanjiubaogao-quanqiuyucejiezhi2023nian/</link>
		
		<dc:creator><![CDATA[chrislee]]></dc:creator>
		<pubDate>Tue, 15 Jan 2019 01:47:45 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[3M]]></category>
		<category><![CDATA[A&D Company]]></category>
		<category><![CDATA[Abbott]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[B. Braun Melsungen AG]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[F. Hoffmann-La Roche AG]]></category>
		<category><![CDATA[Fresenius SE & Co KGaA]]></category>
		<category><![CDATA[GE Healthcare]]></category>
		<category><![CDATA[Home Healthcare]]></category>
		<category><![CDATA[Kinnser Software]]></category>
		<category><![CDATA[KONINKLIJKE PHILIPS N.V.]]></category>
		<category><![CDATA[LG Electronics]]></category>
		<category><![CDATA[Mckesson Corporation]]></category>
		<category><![CDATA[Medtronic PLC]]></category>
		<category><![CDATA[Omron Corporation]]></category>
		<category><![CDATA[家庭医疗保健]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=16976</guid>

					<description><![CDATA[医疗保健和其他诊断设备的各种技术和科学进步以及其他一些政府举措正在鼓励家庭医疗系统在未来几年推动市场需求。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
